YungShin Global Holding Corp
TWSE:3705
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
45.55
62.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
YungShin Global Holding Corp
Net Income (Common)
YungShin Global Holding Corp
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Net Income (Common)
NT$1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Net Income (Common)
NT$255.9m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Net Income (Common)
NT$403m
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Net Income (Common)
NT$138.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-4%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Net Income (Common)
NT$4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Net Income (Common)
NT$854.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
YungShin Global Holding Corp
Glance View
YungShin Global Holding Corp. engages in resources integration and business development. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-01-03. The firm mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The firm also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.
See Also
What is YungShin Global Holding Corp's Net Income (Common)?
Net Income (Common)
1.1B
TWD
Based on the financial report for Jun 30, 2024, YungShin Global Holding Corp's Net Income (Common) amounts to 1.1B TWD.
What is YungShin Global Holding Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
4%
Over the last year, the Net Income (Common) growth was 47%. The average annual Net Income (Common) growth rates for YungShin Global Holding Corp have been 13% over the past three years , 8% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
